Tenjarla Srini
SEC insider (Form 3/4/5 filer). CIK 0002029985. SVP, CMC & Formulation at Serina Therapeutics, Inc. (SER). 2 reported Form 4/5 transactions since Sep 2024; latest on May 21, 2026. Located in HUNTSVILLE, AL.
Companies Tenjarla Srini has filed insider reports for
- Serina Therapeutics, Inc. (SER): Officer, SVP, CMC & Formulation
Tenjarla Srini
CIK: 0002029985
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SER
Serina Therapeutics, Inc.
Officer